Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. 2007

Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. cphra@uottawa.ca

UI MeSH Term Description Entries
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000535 Aluminum A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. Aluminium,Aluminium-27,Aluminum-27,Aluminium 27,Aluminum 27
D000536 Aluminum Hydroxide A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc. Hydrated Alumina,Aldrox,Algeldrate,Alhydrogel,Alugel,Amphojel,Basalgel,Brasivil,Dialume,Nephrox,Pepsamer,Rocgel,Alumina, Hydrated,Hydroxide, Aluminum
D000537 Aluminum Oxide An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories. Alumina,Alumina Ceramic,Aluminum Oxide (Al130O40),Aluminum Oxide (Al2O),Aluminum Oxide (AlO2),Bauxite,Corundum,Sapphire,Ceramic, Alumina,Oxide, Aluminum
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D016273 Occupational Exposure The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation. Exposure, Occupational,Exposures, Occupational,Occupational Exposures
D017607 Aluminum Compounds Inorganic compounds that contain aluminum as an integral part of the molecule. Compounds, Aluminum
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments

Related Publications

Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
June 1983, British medical journal (Clinical research ed.),
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
March 2021, Neurotoxicology,
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
December 1972, The Journal of pharmacy and pharmacology,
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
September 1971, British medical journal,
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
January 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
March 2008, Journal de pharmacie de Belgique,
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
November 1980, Lancet (London, England),
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
October 1973, Proceedings of the Royal Society of Medicine,
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
June 1973, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Daniel Krewski, and Robert A Yokel, and Evert Nieboer, and David Borchelt, and Joshua Cohen, and Jean Harry, and Sam Kacew, and Joan Lindsay, and Amal M Mahfouz, and Virginie Rondeau
May 1981, Lancet (London, England),
Copied contents to your clipboard!